Immunofluorescence of 30 NET G3/NEC patients showed overall varied expression of synaptophysin, CD45, and CD68 as expected with such heterogenous tissues derived from distinct tumor sites, morphologies, and disease stages. This evidence concerns the gene PTPRC and neoplasm.